Predictive Value of NT-proBNP on MACEs After Acute Coronary Syndrome

Completed

• Conditions: Acute Coronary Syndrome; Major Adverse Cardiac Events; ST-segment Elevation Myocardial Infarction (STEMI); Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)

• Registration Number: NCT06569511
• Lead Sponsor: Haseki Training and Research Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-8-21
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 241

Inclusion Criteria

Inclusion Criteria:<br><br> - Adult patients (=18 years old) who were admitted to the emergency department with<br> Acute coronary syndrome and underwent percutaneous coronary intervention between<br> September 2023 and February 2024.<br><br>Exclusion Criteria:<br><br> - patients younger than 18 years<br><br> - patients had no vascular lesions detected on percutaneous coronary intervention,<br><br> - patients had infective or structural cardiac pathologies (myocarditis, pericarditis,<br> hypertrophic or dilated cardiomyopathies)<br><br> - patients had chronic heart failure with LVEF <40%, class 3 and 4 in the Killip<br> classification<br><br> - patients had a diagnosis of malignancy, chronic renal failure, chronic liver<br> failure, and a history of multiple trauma or surgery within the last month

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Predictive ability of NT-proBNP for 6-months MACEs

Secondary Outcome Measures

Name	Time	Method
Incidence of MACEs in STEMI;Incidence of MACEs in NSTEMI;Incidence of MACEs in USAP